These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15716386)

  • 1. Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms.
    Guthrie CR; Murray AT; Franklin AA; Hamblin MW
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1003-10. PubMed ID: 15716386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
    Adham N; Zgombick JM; Bard J; Branchek TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of adenylyl cyclase by endogenous G(s)-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT(7) receptor expression.
    Andressen KW; Norum JH; Levy FO; Krobert KA
    Mol Pharmacol; 2006 Jan; 69(1):207-15. PubMed ID: 16189297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
    Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
    Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization.
    Cohen Z; Bouchelet I; Olivier A; Villemure JG; Ball R; Stanimirovic DB; Hamel E
    J Cereb Blood Flow Metab; 1999 Aug; 19(8):908-17. PubMed ID: 10458598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
    Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
    J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation.
    Lopez-Gimenez JF; Vilaró MT; Milligan G
    Mol Pharmacol; 2008 Nov; 74(5):1278-91. PubMed ID: 18703670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors.
    Janoshazi A; Deraet M; Callebert J; Setola V; Guenther S; Saubamea B; Manivet P; Launay JM; Maroteaux L
    Mol Pharmacol; 2007 Jun; 71(6):1463-74. PubMed ID: 17325130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
    Purohit A; Herrick-Davis K; Teitler M
    Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
    Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
    Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel 5-HT(4) receptor splice variant (r5-HT(4c1)) and preliminary characterisation of specific 5-HT(4a) and 5-HT(4b) receptor antibodies.
    Ray AM; Kelsell RE; Houp JA; Kelly FM; Medhurst AD; Cox HM; Calver AR
    Eur J Pharmacol; 2009 Feb; 604(1-3):1-11. PubMed ID: 19100256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
    Richtand NM; Welge JA; Logue AD; Keck PE; Strakowski SM; McNamara RK
    Prog Brain Res; 2008; 172():155-75. PubMed ID: 18772032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
    Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
    J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.
    Morán A; de Urbina AV; Martín ML; Rodríguez-Barbero A; Román LS
    Eur J Pharmacol; 2009 Oct; 620(1-3):90-6. PubMed ID: 19699736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand dependency of 5-hydroxytryptamine 2C receptor internalization.
    Schlag BD; Lou Z; Fennell M; Dunlop J
    J Pharmacol Exp Ther; 2004 Sep; 310(3):865-70. PubMed ID: 15113845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct functional effects of human 5-HT4 receptor isoforms on beta-amyloid secretion.
    Robert SJ; Lezoualc'h F
    Neurodegener Dis; 2008; 5(3-4):163-5. PubMed ID: 18322379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel interaction between the human 5-HT7 receptor isoforms and PLAC-24/eIF3k.
    De Martelaere K; Lintermans B; Haegeman G; Vanhoenacker P
    Cell Signal; 2007 Feb; 19(2):278-88. PubMed ID: 16935469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.